VGLS Competitors

Pink Sheets . USA . 
Stock . Vg Life Sciences
VGLS Stock  USD 0.0001  0.00  0.00%   
Vg Life Sciences competes with Sino Biopharmaceutica, Dominari Holdings, Pharming Group, and Silo Pharma; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Vg Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Vg Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Vg Life Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Vg Life competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000150.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.00006350.01
Details

Vg Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Vg Life and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of VGLS and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Vg Life Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
LADXD
+ 0.74
ZIVO
DOMH
+ 0.66
ZIVO
DOMH
+ 0.6
LADXD
SBMFF
+ 0.43
PSYBF
RGBPP
+ 0.42
PSYBF
MMIRF
+ 0.38
SBMFF
  
High negative correlations   
MMIRF
- 0.52
KLDO
KLDO
- 0.51
SBMFF
DOMH
- 0.5
KLDO
MMIRF
- 0.47
ZIVO
MMIRF
- 0.41
LADXD
KLDO
- 0.19
PSYBF

Risk-Adjusted Indicators

There is a big difference between VGLS Pink Sheet performing well and Vg Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vg Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
HESG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
PSYBF  623.82  369.70  0.00 (0.65) 0.00 
 0.00 
 0.00 
 0.00 
 20,998 
ZIVO  3.01 (0.58) 0.00  1.03  0.00 
 0.00 
 5.31 
(6.67)
 36.36 
LADXD  295.52  164.26  6.09 (1.05) 16.58 
(409.27)
 23.57 
(30.43)
 9,953 
SBMFF  0.74  0.27  0.00 (0.19) 0.00 
 0.00 
 0.00 
 0.00 
 23.80 
KLDO  164.82  74.08  0.00  0.90  0.00 
 0.00 
 50.00 
(25.00)
 4,849 
RGBPP  28.36  6.26  0.21  0.94  23.00 
(42.53)
 72.73 
(45.00)
 326.47 
DOMH  2.61 (0.07)(0.03) 0.02  3.27 
(2.90)
 6.59 
(4.69)
 23.01 
MMIRF  9.70  4.88  0.00 (20.01) 0.00 
 0.00 
 0.00 
(0.17)
 321.49 
OCTHF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
All Fundamental Data

Vg Life Competitive Analysis

The better you understand Vg Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Vg Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Vg Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
VGLS PSYBF ZIVO LADXD SBMFF KLDO RGBPP DOMH MMIRF OCTHF
 0.00 
 0.0001 
VGLS
 0.00 
 0.0001 
PsyBio
 0.55 
 1.81 
Zivo
 6.67 
 1.96 
LadRx
 2.33 
 0.42 
Sino
 0.00 
 0.01 
Kaleido
 19.60 
 0.08 
Regen
 11.18 
 1.69 
Dominari
 0.00 
 0.06 
MedMira
 0.00 
 0 
Oxford
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Very steady
Unknown risk
Abnormally volatile
Very steady
Out of control
Moderately volatile
Out of control
Very steady
Market Performance
(90 Days Performance)
Solid
OK
Very Weak
Very Weak
Modest
Very Weak
OK
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Below Average
Dangerous
Unknown
Low
Dangerous
Low
Very High
Quite High
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Buy
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Not Rated
Not Rated
Strong Sell
Not Rated
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Current Ratio
0.01
0.89
2.08
1.55
1.42
0.05
N/A
0.14
N/A
Net Asset
1.32 M
4.01 M
2.12 M
60.54 B
50.14 M
559 K
57.56 M
3.83 M
N/A
Profit Margin
N/A
N/A
N/A
0.29
N/A
6.09
-1.8
-2.27
N/A
EBITDA
(3.43 M)
(10.91 M)
(8.73 M)
19.87 B
(85.09 M)
2.65 M
(22.44 M)
(1.07 M)
(5.63 M)
Current Valuation
4.44 M
3.69 M
2.02 M
10.34 B
(16.73 M)
304.65 M
5.52 M
36.69 M
(3.87 M)
Price To Book
32.38
202.42
17.86
2.51
0.0044
N/A
0.25
N/A
0.41
Operating Margin
N/A
N/A
-133.25
0.16
-79.28
-2.96
-0.79
-1.79
N/A
Retained Earnings
(109.84 M)
N/A
(115.8 M)
N/A
(197.63 M)
N/A
(208.76 M)
N/A
N/A
Current Asset
40 K
N/A
28.93 K
13.73 B
72.93 M
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
N/A
0.74
N/A
N/A
N/A
N/A
N/A
Beta
2.76
N/A
0.27
0.51
0.42
3.36
0.97
10.61
N/A
Number Of Employees
1
4
8
25.55 K
76
1
26
15
7
Shares Outstanding
107.88 M
80.85 M
1.82 M
18.81 B
42.62 M
158.73 M
6.28 M
697.45 M
960.42 M
Cash Flow From Operations
(1.91 M)
(6.95 M)
(7.1 M)
5.37 B
(77.09 M)
(606.92 K)
(22.23 M)
(1.88 M)
N/A
Annual Yield
N/A
N/A
0.0424
0.0278
N/A
N/A
N/A
N/A
N/A
Total Debt
3.38 M
207.81 K
445.18 K
5.21 B
5.55 M
1.58 M
3.45 M
40 K
N/A
Return On Equity
N/A
-3.1
-39.56
0.29
-5.81
N/A
-0.47
N/A
N/A
Z Score
N/A
7.2
-87.31
1.2
-6.3
13.2
N/A
N/A
N/A
Return On Asset
-1.51
-0.98
-1.65
0.0451
-1.0
-0.76
-0.17
-0.23
N/A
Book Value Per Share
-0.049
-0.007
-0.63
1.64
0.25
-0.001
6.1
-0.019
0.006
Number Of Shares Shorted
N/A
N/A
35.47 K
N/A
2.34 M
N/A
16 K
N/A
N/A
Current Liabilities
5.46 M
N/A
4.97 M
7.73 B
10.39 M
N/A
N/A
N/A
N/A
Total Asset
1.32 M
4.01 M
2.12 M
60.54 B
50.14 M
559 K
57.56 M
3.83 M
N/A
Target Price
0.15
N/A
36.0
N/A
22.0
N/A
16.0
N/A
N/A
Debt To Equity
N/A
7.03
0.28
0.31
2.05
N/A
N/A
N/A
N/A
Short Ratio
N/A
N/A
6.65
N/A
29.34
N/A
1.45
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
0.083
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
13.23
4.44
14.86
0.36
N/A
7.29
N/A
2.72
Market Capitalization
1.82 M
4.94 M
2 M
10.91 B
421.96 K
335.96 K
9.54 M
77.78 M
11.9 M
Price To Earning
-0.14
N/A
-1.95
24.17
-1.45
-0.88
N/A
-3.72
N/A
Price To Earnings To Growth
N/A
N/A
N/A
0.53
N/A
N/A
N/A
N/A
N/A
Price To Sales
N/A
N/A
2639.17
0.41
0.0425
4.6
0.76
36.63
N/A
Net Income
(6.19 M)
(11.02 M)
(8.75 M)
14.61 B
(90.29 M)
2.44 M
(22.88 M)
(1.83 M)
N/A
Earnings Per Share
-0.071
-0.089
-5.33
0.06
-2.16
-0.017
-3.86
-0.002
N/A
Shares Owned By Insiders
N/A
25.61
25.23
47.86
0.73
54.77
35.43
70.39
44.08
Revenue
N/A
N/A
N/A
26.86 B
1.1 M
235.52 K
2.04 M
952.13 K
N/A
Working Capital
(5.42 M)
N/A
(126.04 K)
6 B
62.54 M
N/A
48.87 M
N/A
N/A
Cash And Equivalents
22.92 K
911.83 K
5.08 M
15.67 B
38.47 M
110.99 K
N/A
396.14 K
N/A
Cash Per Share
N/A
0.01
0.54
0.85
0.9
N/A
N/A
N/A
N/A
Gross Profit
N/A
(1.56 M)
20 K
21.53 B
(66.7 M)
235.52 K
N/A
(512.51 K)
(3.15 M)
Day Typical Price
1.0E-4
1.0E-4
1.82
2.01
0.42
0.01
0.0868
1.68
0.0574
0.0028
Accumulation Distribution
N/A
N/A
0.0688
0.0667
N/A
N/A
26582.4
572.77
N/A
N/A
Market Facilitation Index
N/A
N/A
0.13
0.14
N/A
N/A
0.0
0.0
N/A
N/A
Daily Balance Of Power
9.2 T
0.0
(0.08)
(1.00)
(9,223,372,036,855)
0.0
(0.16)
2.125
0.0
0.0
Period Momentum Indicator
N/A
N/A
(0.01)
(0.14)
(0.01)
N/A
(0.02)
0.17
N/A
N/A
Rate Of Daily Change
9223372 T
1.0
0.99
0.93
0.98
1.0
0.8
1.11
1.0
1.0
Day Median Price
1.0E-4
1.0E-4
1.83
2.03
0.42
0.01
0.09
1.67
0.0574
0.0028
Price Action Indicator
1.0E-4
N/A
(0.02)
(0.14)
(0.01)
N/A
(0.02)
0.1
N/A
N/A
Coefficient Of Variation
N/A
819.35
(722.69)
823.73
1346.71
749.02
660.11
13949.74
794.79
N/A
Mean Deviation
N/A
623.82
3.01
295.52
0.7364
164.82
28.36
2.61
9.7
N/A
Jensen Alpha
N/A
369.7
(0.58)
164.26
0.2708
74.08
6.26
(0.07)
4.88
N/A
Total Risk Alpha
N/A
(73.39)
(1.35)
(35.56)
(0.19)
(10.88)
0.0336
(0.54)
(0.97)
N/A
Sortino Ratio
N/A
N/A
N/A
6.09
N/A
N/A
0.21
(0.03)
N/A
N/A
Downside Variance
N/A
N/A
N/A
590.43
N/A
N/A
1117.98
12.94
N/A
N/A
Standard Deviation
N/A
2572.99
4.62
1219.03
2.42
637.01
47.17
3.67
38.68
N/A
Kurtosis
N/A
66.0
8.23
65.96
20.85
57.86
16.79
2.07
65.5
N/A
Potential Upside
N/A
N/A
5.31
23.57
N/A
50.0
72.73
6.59
N/A
N/A
Treynor Ratio
N/A
(0.65)
1.03
(1.05)
(0.19)
0.8951
0.9432
0.0206
(20.01)
N/A
Maximum Drawdown
N/A
20998.0
36.36
9953.33
23.8
4848.99
326.47
23.01
321.49
N/A
Variance
N/A
6620260.56
21.38
1486027.04
5.87
405781.65
2225.07
13.47
1495.8
N/A
Market Risk Adjusted Performance
N/A
(0.64)
1.04
(1.04)
(0.18)
0.9051
0.9532
0.0306
(20.00)
N/A
Risk Adjusted Performance
N/A
0.1035
(0.1)
0.103
0.0637
0.1123
0.1259
0.0134
0.1062
N/A
Skewness
N/A
8.12
1.35
8.12
1.87
7.6
3.21
0.5284
8.08
N/A
Semi Deviation
N/A
N/A
N/A
16.58
N/A
N/A
23.0
3.27
N/A
N/A
Information Ratio
N/A
0.122
(0.17)
0.1213
0.0225
0.1333
0.1488
(0.03)
0.1226
N/A
Value At Risk
N/A
N/A
(6.67)
(30.43)
N/A
(25.00)
(45.00)
(4.69)
(0.17)
N/A
Expected Short fall
N/A
N/A
N/A
(409.27)
N/A
N/A
(42.53)
(2.90)
N/A
N/A
Downside Deviation
N/A
N/A
N/A
24.3
N/A
N/A
33.44
3.6
N/A
N/A
Semi Variance
N/A
N/A
N/A
274.85
N/A
N/A
528.8
10.69
N/A
N/A

Vg Life Competition Performance Charts

Five steps to successful analysis of Vg Life Competition

Vg Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Vg Life Sciences in relation to its competition. Vg Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Vg Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Vg Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Vg Life Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Vg Life position

In addition to having Vg Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Penny Thematic Idea Now

Penny
Penny Theme
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for VGLS Pink Sheet Analysis

When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY